Page last updated: 2024-09-03

n(6)-carboxymethyllysine and eprosartan

n(6)-carboxymethyllysine has been researched along with eprosartan in 1 studies

Compound Research Comparison

Studies
(n(6)-carboxymethyllysine)
Trials
(n(6)-carboxymethyllysine)
Recent Studies (post-2010)
(n(6)-carboxymethyllysine)
Studies
(eprosartan)
Trials
(eprosartan)
Recent Studies (post-2010) (eprosartan)
803443652978349

Protein Interaction Comparison

ProteinTaxonomyn(6)-carboxymethyllysine (IC50)eprosartan (IC50)
ATP-binding cassette sub-family C member 3Homo sapiens (human)6.65
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.1244
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.1244
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.1217

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hartog, JW; Jaarsma, W; Miyata, T; Plokker, HW; Schalkwijk, CG; Smit, AJ; van de Wal, RM; van Veldhuisen, DJ; van Wijk, LM; Voors, AA1

Trials

1 trial(s) available for n(6)-carboxymethyllysine and eprosartan

ArticleYear
Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction.
    European journal of heart failure, 2010, Volume: 12, Issue:4

    Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diastole; Female; Glycation End Products, Advanced; Humans; Hypertension; Imidazoles; Linear Models; Lysine; Male; Middle Aged; Multivariate Analysis; Netherlands; Skin; Statistics as Topic; Statistics, Nonparametric; Stroke Volume; Thiophenes; Ventricular Function, Left

2010